New Grower Theoretical Cannabis - Various Hypothesis

yes uvb is bad for humans, but for cannabis it cause a protective response the reponse is to coat the plant with resin to protect the plant. we don't have this ability, so we wear cloths and sunglasses.
it would be cool if when we were exposed to uvb we oozed resin to protect our skin. its obvious that to much uvb will kill plant or animal, but its always been there. part of the evolutionary process.
 
I remember reading a study decades ago where music was used to stimulate plant growth, they concluded that classical music (Bach, Beethoven, etc.) caused the best growing conditions, and that Punk, hard rock etc. seemed to actually slow the growing process.
 
I remember reading a study decades ago where music was used to stimulate plant growth, they concluded that classical music (Bach, Beethoven, etc.) caused the best growing conditions, and that Punk, hard rock etc. seemed to actually slow the growing process.

I'm glad you mentioned that. There is more than one good peer reviewed study on the effects of music on plants. I play a 9 hr classical loop for mine. Figure why not, every little bit helps right? :pass:
 
Remember how I wanted to figure out why different variables can cause somewhat psycho/schizo reactions to Cannabis?
Well, this research in the UK touches on that, and partly Isolates the psychological response to being caused from a Genotype - "AKT1".
I posted the link earlier and just now really had the time to look into it - I've also taken the liberty of pasting the most relevant sections of the paper and highlighting the key parts (at least to me).

In Isolating what causes this less than ideal response, they've essentially identified a possibility for stopping it.

However, part of the research team was compensated for their efforts. "CJAM" has consulted for Janssen and GlaxoSmithKline and received compensation. The remaining authors declare no conflict of interest.


Everything cited below is taken from the following link and it's Authors, respectively.
http://www.nature.com/tp/journal/v6/n2/full/tp2015219a.html




These findings are the first to demonstrate that AKT1 mediates the acute response to cannabis in otherwise healthy individuals and implicate the AKT1 pathway as a possible target for prevention and treatment of cannabis psychosis.

The current study, therefore, set out to examine the gene × cannabis use interaction in a group of healthy young cannabis users, with no family history of schizophrenia, assessed both at the time of smoking cannabis and when non-intoxicated. We assessed the impact of the two loci that have been previously demonstrated to have an interaction between psychotic symptoms and cannabis: the functional Valine158Methionine (Val158Met) polymorphism of the COMT gene and AKT1 rs2494732. Given these genotypes have been shown to interact with working memory,11, 12 we included a measure of this in our study. Our novel naturalistic design allowed us to assess (1) acute psychotic symptoms, (2) cognitive function and (3) level of THC, the main active ingredient in the cannabis smoked at the time of ingestion.

Smoking cannabis daily doubles an individual’s risk of developing a psychotic disorder, yet indicators of specific vulnerability have proved largely elusive. Genetic variation is one potential risk modifier. Single-nucleotide polymorphisms in the AKT1 and catechol-O-methyltransferase (COMT) genes have been implicated in the interaction between cannabis, psychosis and cognition, but no studies have examined their impact on an individual’s acute response to smoked cannabis. A total 442 healthy young cannabis users were tested while intoxicated with their own cannabis—which was analysed for delta-9-tetrahydrocannbinol (THC) and cannabidiol content—and also ±7 days apart when drug-free. Psychotomimetic symptoms and working memory were assessed on both the sessions.

In summary, we found that the AKT1 rs2494732 C allele was associated with increased psychotomimetic symptoms after The other factor impacting on acute psychotomimetic response to cannabis was baseline schizotypy. Gender was the only factor to predict acute working memory impairment, with poorer performance in females. When drug free, cannabis dependence weakly predicted schizotypal symptoms and COMT genotype had a marginal impact on working memory, along with ethnicity. The findings of this study contribute to a recent and growing body of evidence suggesting that variation at the AKT1 locus confers details of the risk of cannabis smoking for schizophrenia. This is likely to be in the context of numerous other genetic variants, so the clinical utility at the moment is unclear. It is nonetheless encouraging that there is concordance between genetic influences on acute effects of cannabis and those mediating risk of psychosis.smoking cannabis. However, the fact that AKT1 is relevant to the biology of psychotic symptoms suggests that this might be a promising direction for novel therapeutics for cannabis-induced psychosis.


:data::data::data::data::data::data::data::data::data::data::data::data:
 
Remember how I wanted to figure out why different variables can cause somewhat psycho/schizo reactions to Cannabis?
Well, this research in the UK touches on that, and partly Isolates the psychological response to being caused from a Genotype - "AKT1".
I posted the link earlier and just now really had the time to look into it - I've also taken the liberty of pasting the most relevant sections of the paper and highlighting the key parts (at least to me).

In Isolating what causes this less than ideal response, they've essentially identified a possibility for stopping it.

However, part of the research team was compensated for their efforts. "CJAM" has consulted for Janssen and GlaxoSmithKline and received compensation. The remaining authors declare no conflict of interest.


Everything cited below is taken from the following link and it's Authors, respectively.
http://www.nature.com/tp/journal/v6/n2/full/tp2015219a.html




These findings are the first to demonstrate that AKT1 mediates the acute response to cannabis in otherwise healthy individuals and implicate the AKT1 pathway as a possible target for prevention and treatment of cannabis psychosis.

The current study, therefore, set out to examine the gene × cannabis use interaction in a group of healthy young cannabis users, with no family history of schizophrenia, assessed both at the time of smoking cannabis and when non-intoxicated. We assessed the impact of the two loci that have been previously demonstrated to have an interaction between psychotic symptoms and cannabis: the functional Valine158Methionine (Val158Met) polymorphism of the COMT gene and AKT1 rs2494732. Given these genotypes have been shown to interact with working memory,11, 12 we included a measure of this in our study. Our novel naturalistic design allowed us to assess (1) acute psychotic symptoms, (2) cognitive function and (3) level of THC, the main active ingredient in the cannabis smoked at the time of ingestion.

Smoking cannabis daily doubles an individual’s risk of developing a psychotic disorder, yet indicators of specific vulnerability have proved largely elusive. Genetic variation is one potential risk modifier. Single-nucleotide polymorphisms in the AKT1 and catechol-O-methyltransferase (COMT) genes have been implicated in the interaction between cannabis, psychosis and cognition, but no studies have examined their impact on an individual’s acute response to smoked cannabis. A total 442 healthy young cannabis users were tested while intoxicated with their own cannabis—which was analysed for delta-9-tetrahydrocannbinol (THC) and cannabidiol content—and also ±7 days apart when drug-free. Psychotomimetic symptoms and working memory were assessed on both the sessions.

In summary, we found that the AKT1 rs2494732 C allele was associated with increased psychotomimetic symptoms after The other factor impacting on acute psychotomimetic response to cannabis was baseline schizotypy. Gender was the only factor to predict acute working memory impairment, with poorer performance in females. When drug free, cannabis dependence weakly predicted schizotypal symptoms and COMT genotype had a marginal impact on working memory, along with ethnicity. The findings of this study contribute to a recent and growing body of evidence suggesting that variation at the AKT1 locus confers details of the risk of cannabis smoking for schizophrenia. This is likely to be in the context of numerous other genetic variants, so the clinical utility at the moment is unclear. It is nonetheless encouraging that there is concordance between genetic influences on acute effects of cannabis and those mediating risk of psychosis.smoking cannabis. However, the fact that AKT1 is relevant to the biology of psychotic symptoms suggests that this might be a promising direction for novel therapeutics for cannabis-induced psychosis.


:data::data::data::data::data::data::data::data::data::data::data::data:

I was wondering, if I make a survey to try and isolate if a certain demographic exist and is at a higher risk for this response to cannabis - can I actually get people to participate ? It's long bothered me to hear people say Cannabis makes them "freak out". Many have patiently tried to medicate time and time again to only suffer an unfortunate temporary psychosis (paranoia,anxiety,schizophrenia) so intense that it negates almost all if any positive effects of the medicine.

While medications and now even strains are available without the psychoactive compound (see avatar:biggrin:) that acts as a catalyst for the aforementioned negative side affects, I feel it's still important to help provide a means for ALL to enjoy Delta 9; As I personally feel it's directly equated to one of the best long and short term side effects ever derived from a medicine - a Philosophical, Non - Conformist, Analytical thought process and attitude.
 
Good read, I am very interested in the basic question that we all have, what makes plants grow and produce what we want. I am currently about to do a Greenhouse/LED project at the end of next month with 6 either 7 or 10 gallon trash cans as my DWC rezs and run some grownnorthern LEDs along with the high altitude Colorado Sun at 7,200ft above sea level. I have often thought that the main reason that Cannabis grown in higher altitudes grow bigger and faster because they are like being closer to your indoor lights the closer you are to the sun due to lumen output, I have never thought about the extra UVB. Good stuff
 
Good read, I am very interested in the basic question that we all have, what makes plants grow and produce what we want. I am currently about to do a Greenhouse/LED project at the end of next month with 6 either 7 or 10 gallon trash cans as my DWC rezs and run some grownnorthern LEDs along with the high altitude Colorado Sun at 7,200ft above sea level. I have often thought that the main reason that Cannabis grown in higher altitudes grow bigger and faster because they are like being closer to your indoor lights the closer you are to the sun due to lumen output, I have never thought about the extra UVB. Good stuff

Thanks for stopping by ! That set up u are working towards sounds like my dreams come true! What are you gonna name it, Magic Mountain ? Lulz. All jokes aside be safe ! I'm sure I don't need to tell you, but don't forget to leave room in your budget for security ! :pass:
 
Back
Top